SEC Tracker
Get the app

Vireo Growth VREOF

Vireo Growth closes $60M loan

Form
8-K
Filed
Importance
Routine
  1. $60,000,000 loan with Needham Bank
  2. Refinanced $49M Seller Note
  3. Secured by properties in New York and Florida
  4. Interest rate of 8.5%

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Vireo Growth files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025